Overview
Incidence
Risk Factors
Symptoms
Evaluation
electrocardiogram
heart catheterization
thallium stress test
Treatment
angioplasty
cardiac rehab
drugs
long-term care
questions for doctor
specialist
surgery
Home Care
BP checks
diet
lifestyle
taking control
warning signs
Prevention
diet
Outlook
Complications
dressler's syndrome
Underlying Cause
Anatomy
Ashd (atherosclerotic heart disease) Drugs
Medications that improve blood flow through the coronary arteries include:
- Aspirin:
- Thins the blood, in to order lower the risk of blood clots in the coronary arteries
- Heparin:
- Thins the blood, in to order lower the risk of blood clots in the coronary arteries
- Nitrates:
- Open coronary arteries and let the heart work more efficiently
- Platelet inhibitors:
- Thins the blood, in order to lower the risk of blood clots in the coronary arteries
- Thrombolytics:
- Clot busting medication
- Morphine:
- Reduces anxiety and increased blood flow through coronary arteries
Additional medications that benefit the heart:
- ACE Inhibitors:
- Lower blood pressure and reduce the work of the heart
- Beta-blockers:
- Lower blood pressure and reduce the work of the heart
- Calcium-channel blockers:
- Reduce the work of the heart and reduce abnormal heartbeats
- Statins:
- Lower cholesterol and reduce inflammation inside the coronary arteries
- Clopidogrel (Plavix):
- Thins the blood, in order lower the risk of blood clots in the coronary arteries
- Ranolazine (Ranexa):
- Helps improve oxygen levels in heart muscle.
- This drug is most often used when the above anti-anginal medications are not effective.
For more information:
Continue to Ashd (atherosclerotic heart disease) Long-Term Care
Last Updated: Dec 8, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor
PubMed Ashd (atherosclerotic heart disease) References
- ALLHAT Collaborative Research Group: Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002 Dec 18; 288(23): 2998-3007. [12479764]
- Bild DE, Bluemke DA, Burke GL, et al: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002 Nov 1; 156(9): 871-81. [12397006]
- Brown TL, Merrill J, Hill P, Bengel FM. Relationship of coronary calcium and myocardial perfusion in individuals with chest pain. Assessed by integrated rubidium-82 PET-CT. Nuklearmedizin. 2008;47(6):255-260. [19057799]
- Thuresson M, Jarlov MB, Lindahl B, Svensson L, Zedigh C, Herlitz J. Symptoms and type of symptom onset in acute coronary syndrome in relation to ST elevation, sex, age, and a history of diabetes. Am Heart J. 2005 Aug;150(2):234-42. [16086924]
- Viles-Gonzalez JF, Fuster V, Corti R, Badimon JJ. Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes. Curr Opin Cardiol. 2003 Jul;18(4):286-94. [12858127]